Stay updated on SHP2 Inhibitor BBP-398 Clinical Trial
Sign up to get notified when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.

Latest updates to the SHP2 Inhibitor BBP-398 Clinical Trial page
- Check7 days agoNo Change Detected
- Check14 days agoChange DetectedAdded Revision: v3.4.2. The old 3.4.1 notice and the government funding lapse notice have been removed.SummaryDifference0.5%

- Check21 days agoChange DetectedAdded a site-wide notice about government funding lapse and NIH operations; updated revision from v3.4.0 to v3.4.1.SummaryDifference0.5%

- Check28 days agoChange DetectedThe page now includes a new 'Show glossary' option and a 'Revision: v3.4.0' note. Existing metadata labels were slightly adjusted (for example, 'Last Update Submitted that Met QC Criteria' capitalization changes and 'No FEAR Act Data' replacing the earlier 'No FEAR Act data').SummaryDifference0.2%

- Check42 days agoChange DetectedRevision: v3.3.4 replacing the previous v3.3.3 on the page.SummaryDifference0.1%

- Check64 days agoChange DetectedA consolidated Locations section has been added listing Alabama, California, Colorado, Texas, Utah, Virginia, and Washington under a single header, replacing the previous separate location blocks. The page shows Revision: v3.3.3, and older items like HHS Vulnerability Disclosure and individual state location blocks have been removed.SummaryDifference0.9%

- Check92 days agoChange DetectedThe page revision has been updated from v3.2.0 to v3.3.2.SummaryDifference0.1%

Stay in the know with updates to SHP2 Inhibitor BBP-398 Clinical Trial
Enter your email address, and we'll notify you when there's something new on the SHP2 Inhibitor BBP-398 Clinical Trial page.